Last reviewed · How we verify
levocarnitine propionate
levocarnitine propionate is a Carnitine Analog drug. It is currently in unknown development.
Levocarnitine propionate works by increasing the levels of levocarnitine in the body, which helps to transport fatty acids into the mitochondria for energy production.
Levocarnitine propionate is a carnitine analog, a small molecule drug that has been developed to target a specific condition. However, the target and approved indications for levocarnitine propionate are currently unknown. The drug has a half-life of 1.28 hours, but its bioavailability and commercial status are not well-documented. As a result, levocarnitine propionate is not widely recognized as a treatment option. Further research is needed to fully understand its potential benefits and risks.
At a glance
| Generic name | levocarnitine propionate |
|---|---|
| Drug class | Carnitine Analog |
| Therapeutic area | Gastroenterology |
| Phase | unknown |
Mechanism of action
Think of levocarnitine propionate like a delivery truck that brings fatty acids to the power plants in our cells, called mitochondria. This helps our cells produce energy more efficiently, which can be especially important for people with certain medical conditions. By increasing the levels of levocarnitine, levocarnitine propionate can help improve energy production and reduce fatigue.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- levocarnitine propionate CI brief — competitive landscape report
- levocarnitine propionate updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about levocarnitine propionate
What is levocarnitine propionate?
How does levocarnitine propionate work?
What drug class is levocarnitine propionate in?
What development phase is levocarnitine propionate in?
Related
- Drug class: All Carnitine Analog drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Gastroenterology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing